Insuficiência de convergência ocular associada à Doença de Parkinson: uma revisão sistemática
DOI:
https://doi.org/10.34024/rnc.2024.v32.16637Palavras-chave:
Insuficiência de convergência, movimento ocular, ponto próximo de convergência, doença de ParkinsonResumo
Introdução. A doença de Parkinson (DP) consiste em uma condição clínica neurodegenerativa com etiologia desconhecida. Essa doença apresenta diferentes sintomas visomotores que ainda são pouco investigados e tratados na rotina neurológica clínica e na fisioterapia neurofuncional. A insuficiência de convergência (IC) ocular faz parte dos sintomas visomotores presentes na DP com alta prevalência. Entretanto, até o presente momento, poucos são os estudos que propõem a avaliação e tratamento da IC nos portadores da DP. Objetivo. Discutir a relação entre a IC e a DP. Método. Foi realizada uma revisão sistemática abrangendo todas as publicações pertinentes ao tema indexadas em diferentes bases de dados. Resultados. Foram selecionados 18 artigos sobre o tema, que apresentaram um nível de evidencia Oxford 2B para a maioria. Conclusão. As evidências sugerem que: (1) ocorre uma alta prevalência e sintomatologia de IC na população com a DP; (2) ocorre uma maior IC no grupo com a DP, quando comparado ao grupo controle e (3) na medida em que o estágio da DP avança, parece que a IC aumenta. Mais estudos são necessários para investigar os efeitos dos exercícios ortópticos nos portadores da DP com IC associada.
Métricas
Referências
Morris AD. “James Parkinson: Born April 11, 1755.” Lancet 1955;265:761-3. https://doi.org/10.1016/s0140-6736(55)90558-4
De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol 2006;5:525-35. https://doi.org/10.1016/S1474-4422(06)70471-9
Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm 2017;124:901-5. https://doi.org/10.1007/s00702-017-1686-y
Braak H, Del Tredici K, Rüb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24:197-211. https://doi.org/10.1016/s0197-4580(02)00065-9
Kalyani J, Saravanan SJA, Shankaranarayanan R. Clinical Study on the Ocular Abnormalities in Parkinsonism. J Neurol Neurophysiol 2023;14:1-9. https://doi.org/10.35248/2332-2594.23.14(3).342
Scheiman M, Wick B. General treatment modalities, guidelines and prognosis. In: Scheiman M, Wick B. Clinical management of binocular vision: heterophoric, accommodative and eye movement disorders. Holanda: Wolters Kluwer Health; 2014.
Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson’s disease. Neurology 2004;62:177-80. https://doi.org/10.1212/01.wnl.0000103444.45882.d8
Kergoat H, Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, et al. Orthoptic treatment of convergence insufficiency in Parkinson’s disease: a case series. Gerontol Geriatr Med 2017;3:1-4. https://doi.org/10.1177/2333721417703735
Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Irving EL, et al. Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson’s Disease. Can J Neurol Sci 2017;44:562-6. https://doi.org/10.1017/cjn.2017.39
Scheiman M, Mitchell G, Cotter S. The convergence insufficiency treatment trial: design, methods, and baseline data. The Convergence Insufficiency Trial (CITT) Study Group. Ophthalmic Epidemiol 2008;15:24-36. https://doi.org/10.1080/09286580701772037
Irving EL, Chriqui E, Law C, Kergoat MJ, Leclerc BS, Panisset M, et al. Prevalence of convergence insufficiency in Parkinson’s disease. Mov Disord Clin Pract 2016;4:424-9. https://doi.org/10.1002/mdc3.12453
Kwan SC, Atiya A, Hussaindeen JR, Praveen S, Ambika S. Ocular features of patients with Parkinson’s disease examined at a Neuro-Optometry Clinic in a tertiary eye care center. Indian J Ophthalmol 2022;70:958-61. https://doi.org/10.4103/ijo.IJO_948_21
Borm CD, Werkmann M, de Graaf D, Visser F, Hofer A, Peball M, et al. Undetected ophthalmological disorders in Parkinson’s disease. J Neurol 2022;269:3821-32. https://doi.org/10.1007/s00415-022-11014-0
Lepore FE. Parkinson’s disease and diplopia. Neuro Ophthalmol 2006;30:37-40. https://doi.org/10.1080/01658100600742838
Ekker MS, Janssen S, Seppi K, Poewe W, Vries NM, Theelen T, et al. Ocular and visual disorders in Parkinson’s disease: Common but frequently overlooked. Parkinsonism Relat Disord 2017;40:1-10. https://doi.org/10.1016/j.parkreldis.2017.02.014
Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson’s disease. J Pediatr Ophthalmol Strabismus 1996;33:144-7. https://doi.org/10.3928/0191-3913-19960501-04
Armstrong RA. Visual symptoms in Parkinson’s disease. Int Rev Neurobiol 2017;134:921-46. https://doi.org/10.4061/2011/908306
Dutta P. Oculomotor Dysfunction in Parkinson’s Disease. Eur J Geriatr Gerontol 2020;2:87-90. https://doi.org/10.4274/ejgg.galenos.2020.337
Machan CM, Chriqui E, Law C, Norman B, Alhassan M, Almeida QJ, et al. Changing vergence function in persons with Parkinson’s disease and convergence insufficiency. Parkinsonism Relat Disord 2020;73:41-3. https://doi.org/10.1016/j.parkreldis.2020.03.011
Shibaisaki TS, Kuroiwa Y. Oculomotor abnormalities in Parkinson’s disease. Arch Neurol 1979;36:360-4. https://doi.org/10.1001/archneur.1979.00500420070009
Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX. Ocular motor and sensory function in Parkinson’s disease. Ophthalmology 2012;119:178-82. https://doi.org/10.1016/j.ophtha.2011.06.040
Hanuška J, Bonnet C, Rusz J, Sieger T, Jech R, Rivaud-Péchoux S, et al. Fast vergence eye movements are disrupted in Parkinson’s disease: a video-oculography study. Parkinsonism Relat Disord 2015;21:797-9. https://doi.org/10.1016/j.parkreldis.2015.04.014
Buhmann C, Kraft S, Hinkelmann K, Krause S, Gerloff C, Zangemeister WH. Visual attention and saccadic oculomotor control in Parkinson’s disease. Eur Neurol 2015;73:283-93. https://doi.org/10.1159/000381335
Gupta P, Beylergil S, Murray J, Kilbane C, Ghasia FF, Shaikh AG. Computational models to delineate 3D gaze-shift strategies in Parkinson’s disease. J Neural Eng 2021;18:0460a5. https://doi.org/10.1088/1741-2552/ac123e
Gupta P, Beylergil S, Murray J, Jacobs J, Kilbane C, Shaikh AG, et al. Effects of Parkinson disease on blur-driven and disparity-driven vergence eye movements. J Neuro Ophthalmol 2021;41:442-51. https://doi.org/10.1088/1741-2552/ac123e
Racette BA, Gokden M, Tychsen L, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson’s disease responsive to levodopa. Strabismus 1999;7:169-74. https://doi.org/10.1076/stra.7.3.169.636
Khzam R, El Jalbout ND, Seif R, Sadaka A. An unusual presentation of convergence insufficiency in a patient with Parkinson's disease stimulated by deep brain stimulation. Am J Ophthalmol Case Rep 2022;26:101531. https://doi.org/10.1016/j.ajoc.2022.101531
Vigneau F, Caissie AF, Bors DA. Eye-movement analysis demonstrates strategic influences on intelligence. Intelligence 2006;34:261-72. https://doi.org/10.1167/11.10.10
Cavanagh P. Visual stability based on remapping of attention pointers. Trends Cogn Sci 2010;14:147-53. https://doi.org/10.1016/j.tics.2010.01.007
Bernhardt KA, Poltavski D. Symptoms of convergence and accommodative insufficiency predict engagement and cognitive fatigue during complex task performance with and without automation. Appl Ergon 2021;90:103152. https://doi.org/10.1016/j.apergo.2020.103152
Cosgrove J, Alty JE. Cognitive deficits in Parkinson’s disease: current perspectives. J Parkinsonism Restless Legs Syndr 2018;8:1-11. https://doi.org/10.2147/JPRLS.S125064
Aron AR, Durston S, Eagle DM, Logan GD, Stinear CM, Stuphorn V. Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci 2007;27:11860-4. https://doi.org/10.1523/JNEUROSCI.3644-07.2007
Al-Namaeh M. Ocular manifestations of Parkinson disease. Med Hypot Discov Innov Optometr 2020;1:1-10. https://doi.org/10.51329/mehdioptometry101
Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR. Visual dysfunction in Parkinson’s disease. Brain 2016;139:2827-43. https://doi.org/10.1016/bs.irn.2017.04.007
Montgomery SM, Sirota A, Buzsáki G. Theta and gamma coordination of hippocampal networks during waking and rapid eye movement sleep. J Neurosci 2008;28:6731-41. https://doi.org/10.1523/JNEUROSCI.1227-08.2008
Scheiman M, Mitchell GL, Cotter S, Cooper J, Kulp M, Rouse M. A randomized clinical trial of treatments for convergence insufficiency in children. Arch Ophthalmol 2005;123:14-24. https://doi.org/10.1001/archopht.123.1.14
Scheiman M, Mitchell GL, Cotter S, Kulp MTC, Ooper J, Rouse M, et al. A randomized clinical trial of vision therapy/orthoptics versus pencil pushups for the treatment of convergence insufficiency in young adults. Optometr Vision Sci 2005;82:E583-95. https://doi.org/10.1097/01.opx.0000171331.36871.2f
Birnbaum MH, Soden R, Cohen AH. Efficacy of vision therapy for convergence insufficiency in an adult male population. J Am Optom Assoc 1999;70:225-32. https://pubmed.ncbi.nlm.nih.gov/10457698/
Alvarez TL, Jaswal R, Gohel S, Biswal BB. Functional activity within the frontal eye fields, posterior parietal cortex, and cerebellar vermis significantly correlates to symmetrical vergence peak velocity: an ROI-based, fMRI study of vergence training. Front Integr Neurosci 2014;8:50. https://doi.org/10.3389/fnint.2014.00050
Alvarez TL, Vicci VR, Alkan Y, Kim EH, Gohel S, Barrett AM, et al. Vision therapy in adults with convergence insufficiency: clinical and functional magnetic resonance imaging measures. Optom Vis Sci 2010;87:E985. https://doi.org/10.1097/OPX.0b013e3181fef1aa
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2024 Nélio Silva de Souza, Ana Carolina Gomes Martins, Samantha Medeiros Fonseca, Silmar Silva Teixeira, Victor Hugo do Vale Bastos, Marco Antonio Araújo-Leite
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Como Citar
Aprovado 2024-10-08
Publicado 2024-11-20
